Showing 2501-2510 of 9094 results for "".
Off-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.Neotensil®: A Novel, Noninvasive Solution That Reduces the Appearance of Under-Eye Bags
https://practicaldermatology.com/topics/practice-management/neotensil-a-novel-noninvasive-solution-that-reduces-the-appearance-of-under-eye-bags/19058/Neotensil is the only noninvasive solution clinically proven to reduce the appearance of under-eye bags within an hour, with benefits that last up to 16 hours. Doris Day, MD, discusses the benefits of Neotensil, as well as patient selection, staff training and how to incorporate this unique and effeThe Importance of Planning
https://practicaldermatology.com/topics/practice-management/the-importance-of-planning/19082/Failing to plan is planning to fail, say Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions. They tell aesthetic practices how to lay the foundation for success in minimally invasive procedures.Raising Awareness of Alpha-Gal Syndrome
https://practicaldermatology.com/conferences/noah-worcester/raising-awareness-of-alpha-gal-syndrome/57060/Stephany Vittitow, MD, discusses her resident lecture, “Alpha-Gal Syndrome: A Review,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.The Noah Family
https://practicaldermatology.com/conferences/noah-worcester/the-noah-family/57061/Amy Spizuoco, DO, explains what makes the Noah Worcester Dermatological Society’s annual meetings special and what she took away from the 2026 Annual Meeting.Tips for Treating Children
https://practicaldermatology.com/conferences/noah-worcester/tips-for-treating-children/57066/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, discusses her two Alfred L. Weiner lectures on pediatric dermatology from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.The Latest Skin Cancer Developments
https://practicaldermatology.com/conferences/noah-worcester/the-latest-skin-cancer-developments/57062/Darrell S. Rigel, MD, discusses his presentation, “Skin Cancer Update 2026 – What You Need to Know for Your Practice,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Dermwire TV: 2025 in Review
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-2025-in-review/54093/Dermwire TV takes a look back at the most popular stories from the Practical Dermatology news and multimedia ecosystem.How does chronic AD histopathology evolve from spongiosis-dominant lesions to lichenified, fibrotic plaques?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/Christopher Bunick, MD, FAAD, discusses the roles of the six major cytokines that drive atopic dermatitis pathophysiology: IL-4, IL-13, IL-31, TSLP, IL-22, and IFN-γ.Effector Cell Response Inhibitors
https://practicaldermatology.com/videos/c-suite-chats/effector-cell-response-inhibitors/48960/Excellergy cofounder Alexander Eggel, PhD, and CEO Todd Zavodnick discuss a recent Journal of Allergy and Clinical Immunology article validating the trifunctional mechanism of action of effector cell response inhibitors (ECRIs) for the treatment of allergic diseases, including chronic spontaneous ur